About
Ophthalmic Gene Therapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalGene Therapy, RNA & Peptide Therapy
Team (2)
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
321
By Phase
PHASE1/PHASE2: 2PHASE3: 4
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05555784Collaborator
Evaluation of Impact of Disease and Visual Disability on Quality of Life and Loss of Independence of Patients Living in France With Leber's Hereditary Optic Neuropathy (LHON) Through Qualitative and Quantitative Data Collection
N/ACompleted
12 participants
Started: Aug 4, 2022 · Completed: Feb 2, 2023
NCT03326336Lead Sponsor
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa
PHASE1/PHASE2Active, not recruiting
10 participants
Started: Sep 26, 2018 · Completed: Oct 26, 2027
NCT03293524Lead Sponsor
Efficacy & Safety Study of Bilateral IVT Injection of GS010 in LHON Subjects Due to the ND4 Mutation for up to 1 Year
PHASE3Completed
98 participants
Started: Mar 12, 2018 · Completed: Jul 23, 2024
NCT03406104Lead Sponsor
RESCUE and REVERSE Long-term Follow-up
PHASE3Completed
62 participants
Started: Jan 9, 2018 · Completed: Jul 4, 2022
NCT03295071Lead Sponsor
REALITY LHON Registry
N/ACompleted
44 participants
Started: Jan 3, 2018 · Completed: Jul 1, 2020
Locations (1)
Headquarters
Paris, France
Map
Loading map...